David D. Meek

Insider Reports History

Entity
Individual
Location
3000 Kent Avenue; Suite A1 100, West Lafayette, Indiana
Signature
/s/ Christian Klemt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. Meek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirati Therapeutics, Inc. Chief Executive Officer, Director Common Stock 151K $8.92M $59.02 Jan 20, 2023 Direct
uniQure N.V. Director Ordinary Shares 28.3K $136K $4.81 Jun 19, 2024 Direct
Mirati Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (Right to Buy) 151K Jan 20, 2023 Direct
uniQure N.V. Director Stock Option (Right to Buy) 15.8K Jun 19, 2024 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 15.6K May 15, 2024 Direct
Entasis Therapeutics Holdings Inc. Director Common Stock 0 $2.20 Jul 11, 2022 Direct
Entasis Therapeutics Holdings Inc. Director Stock Option (right to buy) 0 Jul 11, 2022 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Jun 4, 2024 Direct

Insider Reports Filed by David D. Meek

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QURE uniQure N.V. Jun 19, 2024 2 $0 4 Jun 21, 2024 Director
QURE uniQure N.V. Jun 13, 2024 1 -$11.4K 4 Jun 17, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 1 $0 4 Jun 4, 2024 Director
CGEM Cullinan Therapeutics, Inc. May 15, 2024 1 $0 4 May 16, 2024 Director
CGEM Cullinan Therapeutics, Inc. May 15, 2024 0 $0 3 May 16, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Oct 16, 2023 1 $0 4 Oct 16, 2023 Director
FUSN Fusion Pharmaceuticals Inc. Oct 16, 2023 0 $0 3 Oct 16, 2023 Director
QURE uniQure N.V. Jun 13, 2023 3 -$43.2K 4 Jun 20, 2023 Director
QURE uniQure N.V. Feb 27, 2023 1 -$7.67K 4 Mar 1, 2023 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Chief Executive Officer, Director
MRTX Mirati Therapeutics, Inc. Jan 17, 2023 1 -$135K 4 Jan 19, 2023 Chief Executive Officer, Director
MRTX Mirati Therapeutics, Inc. Dec 19, 2022 2 -$187K 4 Dec 21, 2022 Chief Executive Officer, Director
ETTX Entasis Therapeutics Holdings Inc. Jul 7, 2022 4 -$109K 4 Jul 11, 2022 Director
QURE uniQure N.V. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
QURE uniQure N.V. Feb 28, 2022 1 -$10.1K 4 Mar 2, 2022 Director
QURE uniQure N.V. Feb 24, 2022 2 $0 4 Feb 28, 2022 Director
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Chief Executive Officer, Director
MRTX Mirati Therapeutics, Inc. Sep 22, 2021 1 $0 4 Sep 24, 2021 Chief Executive Officer, Director
MRTX Mirati Therapeutics, Inc. Sep 20, 2021 0 $0 3 Sep 24, 2021 Chief Executive Officer, Director
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 4 $0 4 Feb 15, 2022 Director